36 Results for "

PAK4

" in MedChemExpress (MCE) Product Catalog:
Products (36)

36 Results for "PAK4" in MCE Product Catalog:

  • Isoforms Recommended:
  • Targets Recommended:
  • Recombinant Proteins Recommended:
17
17 Publications Verification
Cat. No.: HY-15663
CAS No.: 42521-82-4
Purity:  99.39%
Target:  

PAK

Research Areas:  

Cancer

IPA-3 is a selective non-ATP competitive PAK1 inhibitor with IC50 of 2.5 μM, and shows no inhibition to group II PAKs (PAKs 4-6).
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-13007
CAS No.: 898044-15-0
Purity:  99.79%
Synonyms: PF-03758309
Target:  

PAK Apoptosis

Research Areas:  

Cancer

PF-3758309 (PF-03758309) is a potent, orally available, and reversible ATP-competitive inhibitor of PAK4 (Kd= 2.7 nM; Ki=18.7 nM). PF-3758309 has the expected cellular functions of a PAK4 inhibitor: inhibition of anchorage-independent growth, induction of apoptosis, cytoskeletal remodeling, and inhibition of proliferation .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-19538
CAS No.: 1432908-05-8
Target:  

PAK

Research Areas:  

Cancer

FRAX1036 is a PAK inhibitor with Kis of 23.3 nM, 72.4 nM, and 2.4 μM for PAK1, PAK2 and PAK4, respectively.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-125035
CAS No.: 796888-12-5
Purity:  99.36%
Synonyms: GNF-PF-2356
Target:  

PAK Apoptosis

Research Areas:  

Cancer

LCH-7749944 (GNF-PF-2356) is a potent PAK4 inhibitor with an IC50 of 14.93 μM. LCH-7749944 effectively suppresses the proliferation of human gastric cancer cells through downregulation of PAK4/c-Src/EGFR/cyclin D1 pathway and induces apoptosis .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-12793
CAS No.: 1643913-93-2
Purity:  99.86%
Synonyms: KPT-9274
Target:  

PAK NAMPT

Research Areas:  

Cancer

Padnarsertib (KPT-9274) is an orally bioavailable, dual PAK4/Nicotinamide phosphoribosyltransferase (Nampt) inhibitor, with IC50s of <100 nM and 120 nM, respectively .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-12632
CAS No.: 1394121-05-1
Purity:  99.16%
Target:  

PAK

Research Areas:  

Cancer

GNE 2861 is a PAK inhibitor that displays group II selectivity. GNE 2861 inhibits PAK4, PAK5 and PAK6 with IC50s of 7.5, 36, 126 nM, respectively.
loading...
    loading...
Cat. No.: HY-143490
CAS No.: 2488706-33-6
Purity:  99.78%
Target:  

PAK Apoptosis

Research Areas:  

Cancer

PAK4-IN-2 is a highly potent PAK4 inhibitor with IC50 value of 2.7 nM. PAK4-IN-2 can arrest MV4-11 cells at G0/G1 phase and induce cell apoptosis. PAK4-IN-2 can be used for researching cancer .
loading...
    loading...
Cat. No.: HY-114331
CAS No.: 1620574-24-4
Purity:  99.18%
Research Areas:  

Neurological Disease

DLK-IN-1 (Compound 14) is an orally active, blood-brain barrier-penetrable and selective inhibitor of dual leucine zipper kinase (DLK, MAP3K12) with a Ki value of 3 nM. DLK-IN-1 inhibits Flt3, PAK4, STK33 and TrkA. DLK-IN-1 reduces p-c-Jun. DLK-IN-1 can be used in Alzheimer's disease research .
loading...
    loading...
Cat. No.: HY-N8389
CAS No.: 489-41-8
Globulol is a terpenoid metabolite and Antimicrobial agent. Globulol can be isolated from Alpinia oxyphylla Miq. Globulol binds to PAK4, reduces the expression level of PAK4 in cancer cells, decreases the phosphorylation of AKT, and downregulates the expressions of STAT3, phosphorylated STAT3, and PD-L1. Globulol promotes the secretion of CCL4 by cancer cells. Globulol reduces the viability and proliferation ability of cancer cells, induces G0/G1 cell cycle arrest and Apoptosis in cancer cells, and inhibits cancer cell migration and the integrity of 3D tumor spheres. Globulol enhances the relevant effects of anti-PD-1 agents in the cancer cell microenvironment. Globulol exhibits anticancer activity against liver cancer. Globulol inhibits the mycelial growth of phytopathogenic fungi and the growth of phytopathogenic bacteria. Globulol can be used in studies related to hepatocellular carcinoma .
loading...
    loading...
Cat. No.: HY-174247
Target:  

PROTACs PAK Cadherin

Research Areas:  

Cancer

CPS-021 is a selective PAK4 PROTAC degrader with a DC50 of 50 nM. CPS-021 has potent antimigratory and invasive activity and significantly suppresses the invasion and metastasis of tumor cells in A549-luc lung metastasis mice model . Pink: PAK4 ligand (HY-174822); Blue: CRBN ligase ligand (HY-10984); Black: linker
loading...
    loading...
Cat. No.: HY-130628
CAS No.: 2396529-58-9
Target:  

PAK

Research Areas:  

Cancer

PAK4-IN-1 (Compound 19) is a potent, selective, orally active PAK4 inhibitor with robust anti-tumor efficacy in vivo. PAK4-IN-1 is stable under both acidic and neutral conditions .
loading...
    loading...
Cat. No.: HY-RS09993
Research Areas:  

Others

PAK4 Human Pre-designed siRNA Set A contains three designed siRNAs for PAK4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS09994
Research Areas:  

Others

Pak4 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Pak4 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS09995
Research Areas:  

Others

Pak4 Rat Pre-designed siRNA Set A contains three designed siRNAs for Pak4 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-159897
PAK4-IN-5 (Compound 12i) is a PAK4 inhibitor (IC50: 7.68 nM for PAK4, 1872.01 nM for PAK1). PAK4-IN-5 binds to PAK4 stably via multiple interactions. PAK4-IN-5 inhibits the proliferation and the migratory potential of MDA-MB-231 cells by inhibiting the phosphorylation of PAK4 and LIMK1. PAK4-IN-5 arrests cell cycle in the G0/G1 phase, induces apoptosis and ROS production. LD50: >500 mg/kg for mice (p.o.) .
loading...
    loading...
Cat. No.: HY-174822
CAS No.: 2755835-86-8
Research Areas:  

Others

PAK4-IN-6 is a selective degrader of PAK4. PAK4-IN-6 can be used to synthesize PROTACs such as CPS-021 (HY-174247) .
loading...
    loading...
Cat. No.: HY-117218
CAS No.: 1223284-75-0
Target:  

PAK

Research Areas:  

Cancer

KY-04045 is a PAK4 specific inhibitor (IC50=8.7 μM) that can be used for the development of anticancer drugs targeting PAK4 .
loading...
    loading...
Cat. No.: HY-124764
CAS No.: 468056-29-3
Target:  

PAK

Research Areas:  

Cancer

KY-04031 is a potent PAK4 inhibitor with IC50 of 0.79 μM. KY-04031 binds to the ATP-binding pocket of PAK4. KY-04031 blocks tumor cell growth and invasion .
loading...
    loading...
Cat. No.: HY-124398
CAS No.: 591242-70-5
Target:  

PAK

Research Areas:  

Cancer

GL-1196 is an inhibitor of PAK4. GL-1196 can suppress the proliferation and invasion of gastric cancer cells. GL-1196 inhibits PAK4-mediated signaling pathways. GL-1196 can hinder the proliferation of human gastric cancer cells through suppressing PAK4/c-Src/EGFR/CyclinD1 and CDK4/6. GL-1196 can reduce filamentous pseudopodia formation and induce filamentous pseudopodia formation and promote cell elongation in SGC7901 and BGC823 cells. GL-1196 can be studied in anti-cancer research .
loading...
    loading...
Cat. No.: HY-13007A
CAS No.: 1279034-84-2
Synonyms: PF-03758309 hydrochloride
Target:  

PAK Apoptosis

Research Areas:  

Cancer

PF-3758309 (PF-03758309) hydrochloride is a potent, orally available, and reversible ATP-competitive inhibitor of PAK4 (Kd= 2.7 nM; Ki=18.7 nM). PF-3758309 hydrochloride has the expected cellular functions of a PAK4 inhibitor: inhibition of anchorage-independent growth, induction of apoptosis, cytoskeletal remodeling, and inhibition of proliferation .
loading...
    loading...